Recurrent severe diarrhea with acute kidney injury after drug reinitiation highlights a rare but serious enteropathy linked ...

KERENDIA is a non-steroidal mineralocorticoid receptor antagonist (nsMRA) that selectively and potently blocks mineralocorticoid receptor overactivation in the heart and kidneys. 2 FIND-CKD is the ...

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...

Dimerix will conduct a blinded review of data from its phase III ACTION3 clinical trial in focal segmental glomerulosclerosis ...

Dimerix’s ACTION3 study DMX-200 in focal segmental glomerulosclerosis doses final adult patient with 333 patients recruited ... Read More The post Dimerix doses final patient in Phase III kidney ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...

For patients with uncontrolled hypertension already on two or more medications, monthly injections of tonlamarsen (Kardigan) more effectively lowered plasma angiotensinogen (AGT) levels than a single ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

The Artemis II countdown will begin March 30, setting up a launch attempt on April 1 at 6:24 p.m. Eastern Time.

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

Camber is expanding its launching four new generics.